Stay updated with breaking news from 64026810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a research report report published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other brokerages have also recently issued reports on NKTR. TD Cowen upgraded Nektar Therapeutics from a market perform rating to […]
StockNews.com began coverage on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a research note published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Several other brokerages have also recently issued reports on NKTR. JPMorgan Chase & Co. reiterated an underweight rating on shares of Nektar Therapeutics in […]
Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) have been assigned an average rating of “Reduce” from the seven brokerages that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and one has assigned a buy recommendation to […]
StockNews.com assumed coverage on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a report released on Wednesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other equities research analysts also recently weighed in on NKTR. TD Cowen upgraded shares of Nektar Therapeutics from a market perform rating to an […]
StockNews.com initiated coverage on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a research note published on Wednesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other brokerages have also commented on NKTR. TD Cowen raised shares of Nektar Therapeutics from a market perform rating to an outperform rating […]